Safety and feasibility of umbilical cord mesenchymal stem cells in treatment-refractory systemic lupus erythematosus nephritis: time for a double-blind placebo-controlled trial to determine efficacy

As translational clinical researchers familiar with the risk-benefit of hematopoietic stem cell transplantation in autoimmune diseases, we are intrigued by the recent report of umbilical cord mesenchymal stem cell (UC-MSC) transplantation in treatment-refractory systemic lupus erythematosus nephriti...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodworth, Thasia G, Furst, Daniel E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261567/
https://www.ncbi.nlm.nih.gov/pubmed/25166210
http://dx.doi.org/10.1186/ar4677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261567/
https://www.ncbi.nlm.nih.gov/pubmed/25166210
http://dx.doi.org/10.1186/ar4677

Ejemplares similares